Validamycin A
(Synonyms: 井冈霉素) 目录号 : GC45135
Validamycin A是一种通过抑制海藻糖酶(trehalase)保护作物免受真菌Rhizoctonia solani侵害的农用抗生素类杀菌剂,IC50值为72μM。
Cas No.:37248-47-8
Sample solution is provided at 25 µL, 10mM.
Validamycin A is an agricultural antibiotic fungicide that protects crops from the fungus Rhizoctonia solani by inhibiting trehalase, with an IC50 value of 72μM[1]. Validamycin A also inhibits the growth of Aspergillus flavus (MIC value: 1μg/mL) and is commonly used for controlling diseases such as rice sheath blight and potato black scurf, as well as for studying trehalase activity and trehalose synthesis in biological systems[2,3,4,5].
In vitro, Validamycin A (0.125-1μg/mL), either alone or in combination with amphotericin B (2μg/mL), treatment of human bronchial epithelial cells (BEAS-2B) for 24h did not induce significant cytotoxicity. Validamycin A (1μg/mL) treatment of the Aspergillus flavus ATCC 204304 strain for 24h significantly reduced the adhesion capacity of A. flavus[1]. Validamycin A (1μM) treatment of Rhizoctonia cerealis shake-flask cultures for 8 days significantly reduced the total inositol content in the mycelium (by 62%) and decreased the levels of free and hydrolyzed inositol in the culture supernatant[6].
In vivo, exposure of approximately 100 Aedes aegypti mosquito eggs to rearing medium containing Validamycin A (0.1, 0.2, 0.5mg/mL) in a 200 mL volume, with larvae continuously exposed until the adult stage, significantly delayed hatching, pupation, and eclosion processes, and dose-dependently inhibited the flight ability of adults (100% of adults were unable to fly at the 0.5mg/mL concentration)[7]. Validamycin A (150, 300, 600, 1200mg/kg) co-administered orally with pentylenetetrazol (PTZ) to adult zebrafish, followed by 20min of electroencephalogram (EEG) recording, dose-dependently reduced the number and cumulative duration of PTZ-induced seizure-like EEG activities[8].
References:
[1] PLABOUTONG N, EKRONARONGCHAI S, NIWETBOWORNCHAI N, et al. The inhibitory effect of validamycin A on Aspergillus flavus[J]. International Journal of Microbiology, 2020, 2020(1): 3972415.
[2] ASANO N, YAMAGUCHI T, KAMEDA Y, et al. Effect of validamycins on glycohydrolases of Rhizoctonia solani[J]. The Journal of Antibiotics, 1987, 40(4): 526-532.
[3] GARCÍA M D, ARGÜELLES J C. Trehalase inhibition by validamycin A may be a promising target to design new fungicides and insecticides[J]. Pest Management Science, 2021, 77(9): 3832-3835.
[4] HU F, SU W, LI C, et al. Control Efficacy of Validamycin A (0.2 Billion Spores/ml) Paenibacillus polymyxaDN-1 3% AS for Rice Sheath Blight[J]. Agricultural Science & Technology, 2016, 17(11): 2615.
[5] MATSUURA K. Characteristics of validamycin A in controlling Rhizoctonia diseases[M]//Natural Products. Pergamon, 1983: 301-308.
[6] ROBSON G D, KUHN P J, TRINCI A P J. Effect of validamycin A on the inositol content and branching of Rhizoctonia cerealisand other fungi[J]. Journal of General Microbiology, 1989, 135(4): 739-750.
[7] MARTEN A D, STOTHARD A I, KALERA K, et al. Validamycin A delays development and prevents flight in Aedes aegypti(Diptera: Culicidae)[J]. Journal of Medical Entomology, 2020, 57(4): 1096-1103.
[8] LEE E, BANIK A, LEE K B, et al. Assessment of the novel anti-seizure potential of validamycin A using zebrafish epilepsy model[J]. Molecules, 2024, 29(11): 2572.
Validamycin A是一种通过抑制海藻糖酶(trehalase)保护作物免受真菌Rhizoctonia solani侵害的农用抗生素类杀菌剂,IC50值为72μM[1]。Validamycin A还可抑制Aspergillus flavus生长(MIC值为1μg/mL),通常用于稻穗枯病和土豆黑斑病等病害的控制及生物体中海藻酶活性和海藻糖合成的研究[2,3,4,5]。
在体外,Validamycin A(0.125-1μg/mL)单独或与amphotericin B(2μg/mL)联合处理人支气管上皮细胞(BEAS-2B)24h,未产生显著的细胞毒性。Validamycin A(1μg/mL)处理Aspergillus flavus ATCC 204304菌株24h,显著降低了A. flavus的附着能力[1]。Validamycin A(1μM)处理Rhizoctonia cerealis摇瓶培养物,8天后显著降低了菌丝体中总肌醇含量(降低62%),并减少了培养上清液中游离和水解后肌醇的含量[6]。
在体内,将约100粒埃及伊蚊卵置于含Validamycin A(0.1, 0.2, 0.5mg/mL)的200mL饲养介质中孵化,幼虫持续暴露于药物环境中直至成虫阶段,显著延迟了孵化、化蛹和羽化过程,并以剂量依赖方式抑制了成虫的飞行能力(0.5mg/mL浓度下100%的成虫无法飞行)[7]。Validamycin A(150, 300, 600, 1200mg/kg)与pentylenetetrazol(PTZ)通过口服方式共同给予成年斑马鱼,随后进行20min的脑电图(EEG)记录,可剂量依赖性地减少PTZ诱导的癫痫样脑电活动次数和累计持续时间[8]。
| Cell experiment [1]: | |
Cell lines | BEAS-2B cells (human bronchial epithelial cells) |
Preparation Method | BEAS-2B cells were treated with Validamycin A (0.125, 0.5, 1μg/mL) alone or in combination with amphotericin B (2μg/mL) for 24h. The toxicity of Validamycin A and amphotericin B on BEAS-2B cells using Lactate Dehydrogenase (LDH) Cytotoxicity Colorimetric Assay Kit II. After 24h, LDH reaction mixture was added (25μL) and incubated at 37℃ for 30min. Then, ODs were measured at 450nm using a spectrophotometer. |
Reaction Conditions | 0.125, 0.5, 1μg/mL; 24h |
Applications | Treatment with Validamycin A (0.125-1μg/mL) alone or in combination with amphotericin B (2μg/mL) did not produce significant toxicity to BEAS-2B cells. |
| Animal experiment [2]: | |
Animal models | Adult zebrafish |
Preparation Method | Validamycin A (150, 300, 600, 1200mg/kg) was administered along with PTZ into the mouth of adult zebrafish, and EEG activity in the brain was monitored using noninvasive flat electrodes and perfomed for 20min. |
Dosage form | 150, 300, 600, 1200mg/kg; p.o. |
Applications | Treatment with Validamycin A can reduce the number and cumulative duration of PTZ-induced seizure-like EEG activity. |
References: | |
| Cas No. | 37248-47-8 | SDF | |
| 别名 | 井冈霉素 | ||
| Canonical SMILES | O[C@H]([C@H]1O)[C@H](O)[C@@H](CO)O[C@@]1([H])O[C@H]2[C@H](O)[C@@H](O)[C@@H](N[C@@]3([H])C=C(CO)[C@@H](O)[C@H](O)[C@H]3O)C[C@@H]2CO | ||
| 分子式 | C20H35NO13 | 分子量 | 497.5 |
| 溶解度 | DMSO: 2 mg/ml,PBS (pH 7.2): 10 mg/ml | 储存条件 | 4°C, protect from light, stored under nitrogen |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
![]() |
1 mg | 5 mg | 10 mg |
| 1 mM | 2.0101 mL | 10.0503 mL | 20.1005 mL |
| 5 mM | 402 μL | 2.0101 mL | 4.0201 mL |
| 10 mM | 201 μL | 1.005 mL | 2.0101 mL |
| 第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
| 给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
| 第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >60.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
















